A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve

Journal of Alzheimer's Disease

Volumn 51, Issue 3, 2016, Pages 757-773

  Granger, Matthew W ^a   Franko, Bettina ^a   Taylor, Matthew W ^a   Messier, Claude ^b   St George Hyslop, Peter ^c,d   Bennett, Steffany A L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; amyloid cognitive reserve; learning; memory; Morris water maze; search strategy; stereotypy; transgenic mouse; visual acuity

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; PHOSPHODIESTERASE VI; RETINAL DEGENERATION PHOSPHODIESTERASE 6B; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; PDE6B PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; COGNITIVE RESERVE; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; GENE MUTATION; GENETIC BACKGROUND; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFERENCE MEMORY; SEX DIFFERENCE; SPATIAL LEARNING; STEREOTYPY; VISUAL ACUITY; AMYLOID PLAQUE; ANIMAL; BRAIN; C3H MOUSE; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; SEXUAL DEVELOPMENT; SPATIAL MEMORY; SPATIAL ORIENTATION; SURVIVAL ANALYSIS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITIVE RESERVE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MAZE LEARNING; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PLAQUE, AMYLOID; PSYCHOMOTOR PERFORMANCE; SEX CHARACTERISTICS; SPATIAL MEMORY; SPATIAL NAVIGATION; SURVIVAL ANALYSIS;

EID: 84963717365     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150587     Document Type: Article

References (69)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
2. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: From synapses toward neural networks. Nat Neurosci 13, 812-818.
3. Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: An emperor in need of clothes. Nat Neurosci 15, 349-357.
4. Zahs KR, Ashe KH (2010) 'Too much good news'-are Alzheimer mouse models trying to tell us howto prevent, not cure, Alzheimer's disease? Trends Neurosci 33, 381-389.
5. Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ (2014) Using mice to model Alzheimer's dementia: An overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5, 88.
6. Hochgrafe K, Sydow A, Mandelkow EM (2013) Regulatable transgenic mouse models of Alzheimer disease: Onset, reversibility and spreading of Tau pathology. FEBS J 280, 4371-4381.
7. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
8. Barron AM, Rosario ER, Elteriefi R, Pike CJ (2013) Sexspecific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: Implications for Alzheimer's disease. PLoS One 8, e78554.
9. Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, Broersen LM, Lutjohann D, Heerschap A, Kiliaan AJ (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis 33, 482-498.
10. Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR (2005) Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18, 602-617.
11. Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z (2011) Soluble Abeta levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res 222, 342-350.
12. MielkeMM, Vemuri P, RoccaWA (2014) Clinical epidemiology of Alzheimer's disease: Assessing sex and gender differences. Clin Epidemiol 6, 37-48.
13. Barnes LL,Wilson RS, Bienias JL, Schneider JA,EvansDA, BennettDA(2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62, 685-691.
14. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Roberts RO, Lowe VJ, Kantarci K, Senjem ML, Gunter JL, Boeve BF, Petersen RC, JackCRJr (2012) Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol 72, 730-738.
15. Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging I (2010) Sex and age differences in atrophic rates: An ADNI study with n=1368 MRI scans. Neurobiol Aging 31, 1463-1480.
16. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM, Alzheimer's Disease Neuroimaging, Initiative (2010) Brain atrophy in healthy aging is related to CSF levels of Abeta1-42. Cereb Cortex 20, 2069-2079.
17. Snowdon DA (2003) Healthy aging and dementia: Findings from the Nun Study. Ann Intern Med 139, 450-454.
18. ThiesW, Bleiler L, Alzheimer'sA(2013) 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9, 208-245.
19. Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778-1783.
20. Irvine K, Laws KR, Gale TM, Kondel TK (2012) Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis. J Clin Exp Neuropsychol 34, 989-998.
21. Perneczky R, Drzezga A, Diehl-Schmid J, Li Y, Kurz A (2007) Gender differences in brain reserve: An (18)F-FDG PET study in Alzheimer's disease. J Neurol 254, 1395-1400.
22. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M,Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
23. Stern Y (2012) Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 11, 1006-1012.
24. Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, McGaugh JL, LaFerla FM (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 28, 76-82.
25. Gallagher JJ, Minogue AM, Lynch MA (2013) Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Abeta accumulation and microglial activation. Neurodegener Dis 11, 33-41.
26. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216, 92-103.
27. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158, 1173-1177.
28. Schafer S,Wirths O, Multhaup G, Bayer TA (2007) Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm 114, 387-394.
29. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T (2003) Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14, 318-327.
30. Placanica L, Zhu L, Li YM (2009) Gender-and agedependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease. PLoS One 4, e5088.
31. Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, De Koninck Y, Calon F (2012) Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One 7, e46111.
32. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in beta-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure. Brain Res 1366, 233-245.
33. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M,Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS,WestawayD(2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562-21570.
34. Janus C (2004) Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learn Mem 11, 337-346.
35. Lovasic L, Bauschke H, Janus C (2005) Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Genes Brain Behav 4, 197-208.
36. Wang F, Blanchard AP, Elisma F, Granger M, Xu H, Bennett SAL, Figeys D, Zou H (2013) Phosphoproteome analysis of an early onset mouse model (TgCRND8) of Alzheimer's disease reveals temporal changes in neuronal and glia signaling pathways. Proteomics 13, 1292-1305.
37. Gimenez E, Montoliu L (2001) A simple polymerase chain reaction assay for genotyping the retinal degeneration mutation (Pdeb(rd1)) in FVB/N-derived transgenic mice. Lab Anim 35, 153-156.
38. Franklin KBJ, Paxinos GT (2007) The Mouse Brain in Stereotaxic Coordinates, Elesvier Academic Press, New York.
39. Hof PY, Bloom FE, Belichenko PV, Celio MR (2001) Comparative Cytoarchitectonic Atlas of the C57Bl/6 and 129/Sv Mouse Brains., Elsevier Science, London, UK.
40. Pettit AS, Desroches R, Bennett SA (2012) The opiate analgesic buprenorphine decreases proliferation of adult hippocampal neuroblasts and increases survival of their progeny. Neuroscience 200, 211-222.
41. Dong HW, Swanson LW, Chen L, Fanselow MS, Toga AW (2009) Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proc Natl Acad Sci U S A 106, 11794-11799.
42. Brody DL, HoltzmanDM(2006) Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197, 330-340.
43. Wolfer DP, Lipp HP (2000) Dissecting the behaviour of transgenic mice: Is it the mutation, the genetic background, or the environment? Exp Physiol 85, 627-634.
44. Gil-Pages M, Stiles RJ, Parks CA, Neier SC, Radulovic M, Oliveros A, Ferrer A, Reed BK, Wilton KM, Schrum AG (2013) Slow angled-descent forepaw grasping (SLAG): An innate behavioral task for identification of individual experimental mice possessing functional vision. Behav Brain Funct 9, 35.
45. Hussain AA,Willmott NJ, Voaden MJ (1992) Cyclic GMP, calcium and photoreceptor sensitivity in mice heterozygous for the rod dysplasia gene designated "rd".Vision Res 32, 29-36.
46. McLean AC, Valenzuela N, Fai S, Bennett SA (2012) Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp, e4389.
47. Guehne U, Luck T, Busse A, Angermeyer MC, Riedel-Heller SG (2007) Mortality in individuals with mild cognitive impairment. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Neuroepidemiology 29, 226-234.
48. Francis BM, Kim J, Barakat ME, Fraenkl S, Yucel YH, Peng S, Michalski B, Fahnestock M, McLaurin J, MountHT (2012) Object recognition memory and BDNF expression are reduced in young TgCRND8 mice. Neurobiol Aging 33, 555-563.
49. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25, 4217-4221.
50. Hyde LA, Kazdoba TM, Grilli M, Lozza G, Brusa R, Zhang Q,WongGT,McCoolMF, Zhang L, ParkerEM,HigginsGA (2005) Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav Brain Res 160, 344-355.
51. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR (2002) Retinal degeneration mutants in the mouse. Vision Res 42, 517-525.
52. Walker JM, Klakotskaia D, Ajit D, Weisman GA, Wood WG, SunGY, Serfozo P, Simonyi A, Schachtman TR (2015) Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model. J Alzheimers Dis 44, 561-572.
53. Walker JM, Fowler SW, Miller DK, Sun AY,Weisman GA, Wood WG, Sun GY, Simonyi A, Schachtman TR (2011) Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Behav Brain Res 222, 169-175.
54. Lin KA, Doraiswamy PM (2014) When Mars versus Venus is not a cliche: Gender differences in the neurobiology of Alzheimer's disease. Front Neurol 5, 288.
55. Li JQ, Tan L, Wang HF, Tan MS, Tan L, Xu W, Zhao QF, Wang J, Jiang T, Yu JT (2015) Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: A systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry, published online first May 22 2015, doi: 10.1136/jnnp-2014-310095
56. Ambree O, Touma C, Gortz N, Keyvani K, Paulus W, Palme R, Sachser N (2006) Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Neurobiol Aging 27, 955-964.
57. Vassilaki M, Cha RH, Geda YE, Mielke MM, Knopman DS, Petersen RC, Roberts RO (2015) Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: The mayo clinic study of aging. J Alzheimers Dis 45, 1237-1245.
58. Contador I, Bermejo-Pareja F, Mitchell AJ, Trincado R,Villarejo A, Sanchez-Ferro A, Benito-Leon J (2014) Cause of death in mild cognitive impairment: A prospective study (NEDICES). Eur J Neurol 21, 253-e259.
59. Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC (2015) Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-amyloid across the adult life span. JAMA Neurol 72, 511-519.
60. Sobral M, Pestana MH, Paul C (2015) Cognitive reserve and the severity of Alzheimer's disease. Arq Neuropsiquiatr 73, 480-486.
61. Palm R, Ayala-Fontanez N, Garcia Y, Lee HG, Smith MA, Casadesus G (2012) Neuroendocrinology-based therapy for Alzheimer's disease. Biofactors 38, 123-132.
62. Valero J, Mastrella G, Neiva I, Sanchez S, Malva JO (2014) Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory. Front Neurosci 8, 83.
63. Verret L, Krezymon A, Halley H, Trouche S, Zerwas M, Lazouret M, Lassalle JM, Rampon C (2013) Transient enriched housing before amyloidosis onset sustains cognitive improvement in Tg2576 mice. Neurobiol Aging 34, 211-225.
64. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25, 5217-5224.
65. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62, 1220-1227.
66. Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW (2007) Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 88, 277-294.
67. Herring A, Ambree O, Tomm M, Habermann H, Sachser N, Paulus W, Keyvani K (2009) Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol 216, 184-192.
68. Herring A, Yasin H, Ambree O, Sachser N, Paulus W, Keyvani K (2008) Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice. Brain Pathol 18, 32-39.
69. Richter H, Ambree O, Lewejohann L, Herring A, Keyvani K, Paulus W, Palme R, Touma C, Schabitz WR, Sachser N (2008) Wheel-running in a transgenic mouse model of Alzheimer's disease: Protection or symptom? Behav Brain Res 190, 74-84.